SenesTech, Inc. (SNES)
NASDAQ: SNES · IEX Real-Time Price · USD
0.512
-0.067 (-11.57%)
At close: Jul 2, 2024, 4:00 PM
0.530
+0.018 (3.52%)
Pre-market: Jul 3, 2024, 5:11 AM EDT
Company Description
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control.
It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc.
| Country | United States |
| Founded | 2004 |
| IPO Date | Dec 8, 2016 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 25 |
| CEO | Joel L. Fruendt |
Contact Details
Address: 3140 N. Caden Court, Suite 1 Flagstaff, Arizona 86004 United States | |
| Phone | (928) 779 - 4143 |
| Website | senestech.com |
Stock Details
| Ticker Symbol | SNES |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001680378 |
| CUSIP Number | 81720R208 |
| ISIN Number | US81720R5054 |
| Employer ID | 20-2079805 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Joel L. Fruendt | Chief Executive Officer, President and Director |
| Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer and Secretary |
| Robert Blum | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 20, 2024 | 424B5 | Filing |
| Jun 20, 2024 | 8-K | Current Report |
| May 28, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 28, 2024 | DEF 14A | Other definitive proxy statements |
| May 15, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| May 14, 2024 | PRE 14A | Other preliminary proxy statements |
| May 9, 2024 | 10-Q | Quarterly Report |
| May 9, 2024 | 8-K | Current Report |
| May 1, 2024 | 8-K | Current Report |
| Apr 29, 2024 | 10-K/A | [Amend] Annual report |